Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial
- PMID: 26755682
- PMCID: PMC5007741
- DOI: 10.1093/gerona/glv228
Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial
Abstract
Background: The Systolic Blood Pressure Intervention Trial (SPRINT) is testing whether a lower systolic blood pressure (BP) target of 120 mm Hg leads to a reduction in cardiovascular morbidity and mortality among hypertensive, nondiabetic adults. Because there may be detrimental effects of intensive BP control, particularly in older, frail adults, we sought to characterize frailty within SPRINT to address ongoing questions about the ability of large-scale trials to enroll representative samples of noninstitutionalized, community-dwelling, older adults.
Methods: We constructed a 36-item frailty index (FI) in 9,306 SPRINT participants, classifying participants as fit (FI ≤ 0.10), less fit (0.10 < FI ≤ 0.21), or frail (FI > 0.21). Recurrent event models were used to evaluate the association of the FI with the incidence of self-reported falls, injurious falls, and all-cause hospitalizations.
Results: The distribution of the FI was comparable with what has been observed in population studies, with 2,570 (27.6%) participants classified as frail. The median FI was 0.18 (interquartile range = 0.14 to 0.24) in participants aged 80 years and older (N = 1,159), similar to the median FI of 0.17 reported for participants in the Hypertension in the Very Elderly Trial. In multivariable analyses, a 1% increase in the FI was associated with increased risk for self-reported falls (hazard ratio [HR] = 1.030), injurious falls (HR = 1.035), and all-cause hospitalizations (HR = 1.038) (all p values < .0001).
Conclusions: Large clinical trials assessing treatments to reduce cardiovascular disease risk, such as SPRINT, can enroll heterogeneous populations of older adults, including the frail elderly, comparable with general population cohorts.
Keywords: Falls; Frailty; Multimorbidities.
© The Author 2016. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
References
-
- James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–520. doi:10.1001/jama.2013.284427 - PubMed
-
- Wright JT, Fine LJ, Lackland DT, et al. Evidence supporting a systolic blood pressure goal of less than 150mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med. 2014;160:499–503. doi:10.7326/M13-2981 - PubMed
-
- Weisberg HI, Hayden VC, Pontes VP. Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality? Clin Trials. 2009;6:109–118. doi:10.1177/1740774509102563 - PubMed
-
- Morley JE. Systolic hypertension should not be treated in persons aged 80 and older until blood pressure is greater than 160 mmHg. J Am Geriatr Soc. 2013;61:1197–1198. doi:10.1111/jgs.12322_1 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UL1 TR000433/TR/NCATS NIH HHS/United States
- UL1 TR001070/TR/NCATS NIH HHS/United States
- UL1TR000050/TR/NCATS NIH HHS/United States
- HHSN268200900046C/PHS HHS/United States
- UL1TR000093/TR/NCATS NIH HHS/United States
- UL1TR000073/TR/NCATS NIH HHS/United States
- UL1RR025755/RR/NCRR NIH HHS/United States
- UL1RR025771/RR/NCRR NIH HHS/United States
- P30 GM103337/GM/NIGMS NIH HHS/United States
- UL1 TR001064/TR/NCATS NIH HHS/United States
- UL1TR000433/TR/NCATS NIH HHS/United States
- HHSN268200900040C/PHS HHS/United States
- UL1 RR025752/RR/NCRR NIH HHS/United States
- UL1TR000105-05/TR/NCATS NIH HHS/United States
- UL1RR025752/RR/NCRR NIH HHS/United States
- HHSN268200900048C/PHS HHS/United States
- UL1 TR000093/TR/NCATS NIH HHS/United States
- A-HL-13-002-001/HL/NHLBI NIH HHS/United States
- R01 HL107241/HL/NHLBI NIH HHS/United States
- P30GM103337/GM/NIGMS NIH HHS/United States
- UL1TR000003/TR/NCATS NIH HHS/United States
- UL1 TR000073/TR/NCATS NIH HHS/United States
- UL1 TR001085/TR/NCATS NIH HHS/United States
- R01 HL130500/HL/NHLBI NIH HHS/United States
- HHSN268200900049C/PHS HHS/United States
- UL1TR000439/TR/NCATS NIH HHS/United States
- UL1 TR000002/TR/NCATS NIH HHS/United States
- UL1 TR002240/TR/NCATS NIH HHS/United States
- HHSN268200900047C/PHS HHS/United States
- UL1TR001064/TR/NCATS NIH HHS/United States
- UL1RR024134/RR/NCRR NIH HHS/United States
- UL1TR000075/TR/NCATS NIH HHS/United States
- P30 AG021332/AG/NIA NIH HHS/United States
- UL1 TR000445/TR/NCATS NIH HHS/United States
- UL1 TR001067/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
